On Monday, Halozyme Therapeutics, Inc. (NASDAQ:HALO)’s shares declined -3.12% to $16.79.
Halozyme Therapeutics, Inc. (HALO) declared the Pancreas Center at the University of California, San Francisco (UCSF) has initiated a clinical research study of Halozyme’s investigational new drug, PEGPH20 in pancreatic cancer patients who are candidates for potentially curative surgery. The trial will be conducted within the UCSF Helen Diller Family Comprehensive Cancer Center.
The Phase 2 study will investigate PEGPH20 in combination with gemcitabine and nab-paclitaxel (ABRAXANE) in patients with borderline resectable Pancreatic Ductal Adenocarcinoma (PDAC). The study will track the progress of up to 36 patients through chemotherapy and surgical treatment.
PEGPH20 (PEGylated recombinant human hyaluronidase) targets the degradation of hyaluronan (HA), a chain of natural sugars that can accumulate around cancer cells, inhibiting other therapies. By degrading HA, PEGPH20 may enhance the access of co-administered chemotherapeutic and immunotherapeutic agents.
Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other drugs or can be used to alter abnormal tissue structures for clinical benefit.
Albemarle Corporation (NYSE:ALB)’s shares dropped -5.28% to $44.34.
Chemetall, a Global Business Unit of Albemarle Corporation (ALB), has introduced a new water-based penetrant for eco-friendly and process efficient fluorescent penetrant inspection. Britemor® 921 (W) enables bright and crisp indications on a wide range of materials, counting ferrous and non-ferrous metals, and non-porous ceramics, thanks to its very low fluorescent background and excellent wash characteristics. Chemetall’s liquid penetrant testing product uses water as the main carrier which is stabilized by a distinctive micro-emulsion technology. These micro-emulsions are thermodynamically stable and composition comprises isotropic liquid mixtures of solvent, water and emulsifier. The low viscosity of the Britemor® 921 (W) ensures minimal drag out, reduces overall product and rinse water consumption and minimizes the effluent treatment costs.
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. The company’s Performance Chemicals segment offers brominated flame retardants under the Saytex brand; mineral-based flame retardants under the Martinal and Magnifin brands; and elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and bromine fine chemicals that are used in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, paper manufacturing, water purification, beef and poultry processing, and various other industrial applications.
At the end of Monday’s trade, DTE Energy Co (NYSE:DTE)‘s shares dipped -4.78% to $79.21.
Peter Oleksiak, DTE Energy senior vice president and chief financial officer, will provide a business update at the Barclays CEO Energy - Power Conference on Thursday, Sept. 10, 2015.
The 30-minute presentation is planned to start at 7:45 a.m. ET.
DTE Energy Company operates in the utility operations. The company’s Electric segment engages in the generation, purchase, distribution, and sale of electricity to about 2.1 million residential, commercial, and industrial customers in southeastern Michigan. It generates electricity through fossil-fuel, hydroelectric pumped storage, and nuclear plants, in addition to wind and other renewable assets. This segment owns and operates about 675 distribution substations; and about 432,900 line transformers. Its Gas segment is involved in the purchase, storage, transportation, distribution, and sale of natural gas to about 1.2 million residential, commercial, and industrial customers in Michigan, in addition to in the sale of storage and transportation capacity. This segment has about 19,000 miles of distribution mains, 1,162,000 service pipelines, and 1,313,000 active meters; and owns about 2,000 miles of transmission pipelines.
FMC Corp (NYSE:FMC), ended its Monday’s trading session with -3.36% loss, and closed at $43.14.
FMC Corporation (FMC) declared that it will establish a Europe FMC Corp(NYSE:FMCan regional headquarters and research facility in Horsholm, a suburb of Copenhagen, Denmark. The new FMC European Innovation Center (EIC), predictable to open in 2016, will serve as a central hub for research and development, regional corporate functions and regional commercial teams.
The new center will be located at the Scion DTU Science and Technology Park in Horsholm, about 25 kilometers north of Copenhagen. It will bring together employees who presently work at sites throughout Europe and the U.S., counting employees in research, sales, marketing, regional administration, finance, supply chain, human resources and related functions.
FMC Corporation, a diversified chemical company, provides solutions, applications, and products for the agricultural, consumer, and industrial markets in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through three segments: FMC Agricultural Solutions, FMC Health and Nutrition, and FMC Lithium. The FMC Agricultural Solutions segment develops, manufactures, and sells crop protection, professional pest control, and lawn and garden products, such as insecticides, herbicides, and fungicides.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
